Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05863871

Real World Study of Linperlisib for Lymphoma Treatment

Sponsor: Ruijin Hospital

View on ClinicalTrials.gov

Summary

This is a multicenter, non-interventional and observational real-world study to evaluate the efficacy and safety of linperlisib in patients with lymphoma.

Official title: Real World Study of Linperlisib for Lymphoma Treatment: Multicenter, Non-interventional and Observational Real-world Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2023-05

Completion Date

2027-06

Last Updated

2023-05-18

Healthy Volunteers

No

Interventions

DRUG

Linperlisib

80 mg, qd

Locations (2)

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China

Tianjin Cancer Hospital/ Tianjin medical university cancer institute & hospital

Tianjin, China